Standard treatment of advanced-stage diffuse large B-cell lymphoma.
about
Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).Rituximab therapy in malignant lymphoma.Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy.Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment
P2860
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@ast
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@en
type
label
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@ast
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@en
prefLabel
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@ast
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@en
P1476
Standard treatment of advanced-stage diffuse large B-cell lymphoma.
@en
P2093
Bertrand Coiffier
P304
P356
10.1053/J.SEMINHEMATOL.2006.07.004
P577
2006-10-01T00:00:00Z